Brief: DermTech Reports Positive Topline Results From Trust 2 Study
Jan 8 (Reuters) - DermTech Inc DMTKW.PK :
* DERMTECH ANNOUNCES POSITIVE TOPLINE RESULTS FROM TRUST 2
STUDY
EVALUATING THE DERMTECH MELANOMA TEST (DMT)
* DERMTECH INC - TRUST 2 STUDY DEMONSTRATED POWERFUL
CLINICAL
UTILITY FOR DMT AS A RULE-OUT TEST FOR MELANOMA
Source text for Eikon: ID:nBw9YFYs7a
Further company coverage: DMTKW.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DermTech
See all newsBrief: Dermtech Announces Completion Of Workforce Reduction And One-Time Charge To Be Incurred In Q2
DermTech shares sink after filing for bankruptcy
Brief: Dermtech Files For Voluntary Chapter 11 Protection
Brief: Dermtech Inc Files For Chapter 11 Bankruptcy- Court Filing
Brief: DermTech To Explore Strategic Alternatives, Implement Restructuring Plan